Revolutionary drug for schizophrenia wins US approval
Elie Dolgin • September 26, 2024
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.
Read at Nature.
Molecular signatures of aging are changing how conservationists assess population health, resilience and risk.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.